Literature DB >> 26458281

Serological diagnosis of Toxoplasma gondii infection: Recommendations from the French National Reference Center for Toxoplasmosis.

O Villard1, B Cimon2, C L'Ollivier3, H Fricker-Hidalgo4, N Godineau5, S Houze6, L Paris7, H Pelloux4, I Villena8, E Candolfi9.   

Abstract

Toxoplasmosis manifests no clinical signs in 80% of cases in immunocompetent patient, causing immunization characterized by the persistence of cysts, particularly in brain, muscles, and retina. Assessing the serological status, based on testing for serum toxoplasma IgG and IgM antibodies, is essential in cases that are increasingly at risk for the more severe disease forms, such as congenital or ocular toxoplasmosis. This disease also exposes immunosuppressed patients to reactivation, which can lead to more widespread forms and increased mortality. By interpreting the serological results, we can estimate the risk of contamination or reactivation and define appropriate prophylactic and preventive measures, such as hygienic and dietetic, therapeutic, biological, and clinical follow-up, according to the clinical context. We hereby propose practical approaches based on serological data, resulting from a consensus of a group of experts from the French National Reference Center Network for Toxoplasmosis, according to both routine and specific clinical situations.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical situations; Recommendations; Serological diagnosis; Toxoplasma; Toxoplasmosis

Mesh:

Substances:

Year:  2015        PMID: 26458281     DOI: 10.1016/j.diagmicrobio.2015.09.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  46 in total

1.  Human Immunoglobulin Heavy Gamma Chain Polymorphisms: Molecular Confirmation Of Proteomic Assessment.

Authors:  Magalie Dambrun; Célia Dechavanne; Alexandra Emmanuel; Florentin Aussenac; Marjorie Leduc; Chiara Giangrande; Joëlle Vinh; Jean-Michel Dugoujon; Marie-Paule Lefranc; François Guillonneau; Florence Migot-Nabias
Journal:  Mol Cell Proteomics       Date:  2017-03-06       Impact factor: 5.911

Review 2.  Toxoplasmosis in Germany.

Authors:  Uwe Pleyer; Uwe Gross; Dirk Schlüter; Henrik Wilking; Frank Seeber
Journal:  Dtsch Arztebl Int       Date:  2019-06-21       Impact factor: 5.594

3.  Evaluation of a New Immunochromatography Technology Test (LDBio Diagnostics) To Detect Toxoplasma IgG and IgM: Comparison with the Routine Architect Technique.

Authors:  Caroline Mahinc; Pierre Flori; Edouard Delaunay; Cécile Guillerme; Sana Charaoui; Hélène Raberin; Jamal Hafid; Coralie L'Ollivier
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

4.  Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis.

Authors:  O Villard; B Cimon; C L'Ollivier; H Fricker-Hidalgo; N Godineau; S Houze; L Paris; H Pelloux; I Villena; E Candolfi
Journal:  J Clin Microbiol       Date:  2016-10-12       Impact factor: 5.948

5.  Toxoplasma genotyping in congenital toxoplasmosis in Upper Egypt: evidence of type I strain.

Authors:  Hanan E M Eldeek; Alzahraa Abdel Raouf Ahmad; Mohamed Ahmed El-Mokhtar; Abdel Rahman M M Abdel Kader; Ahmad M Mandour; Mahmoud Elhady M Mounib
Journal:  Parasitol Res       Date:  2017-07-01       Impact factor: 2.289

6.  Congenital Toxoplasmosis in Tunisia: Prenatal and Neonatal Diagnosis and Postnatal Follow-up of 35 Cases.

Authors:  Yosr Boudaouara; Karim Aoun; Rania Maatoug; Olfa Souissi; Aïda Bouratbine; Rym Ben Abdallah
Journal:  Am J Trop Med Hyg       Date:  2018-04-12       Impact factor: 2.345

7.  Comparisons of Toxoplasma gondii Prevalence in Rural and Urban Areas of Al-Najaf Province of Iraq Using Serological Methods.

Authors:  K Abdul Ameer Jaber; R Aamer Noori
Journal:  Arch Razi Inst       Date:  2021-12-30

8.  Spinal cord toxoplasmosis in a young immunocompetent patient.

Authors:  M Martinot; V Greigert; C Farnarier; M L Dardé; C Piperoglou; M Mohseni-Zadeh; J Tarabeux; A Guffroy; O Villard; F Vely
Journal:  Infection       Date:  2019-12-09       Impact factor: 3.553

9.  Production of anti-SAG1 IgY antibody against Toxoplasma gondii parasites and evaluation of antibody activity by ELISA method.

Authors:  Rabia Cakir-Koc
Journal:  Parasitol Res       Date:  2016-04-15       Impact factor: 2.289

Review 10.  Role of Toxoplasma gondii IgG Avidity Testing in Discriminating between Acute and Chronic Toxoplasmosis in Pregnancy.

Authors:  Aref Teimouri; Sina Mohtasebi; Elham Kazemirad; Hossein Keshavarz
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.